Solvonis Therapeutics PlcSolvonis Therapeutics PlcSolvonis Therapeutics Plc

Solvonis Therapeutics Plc

No trades
See on Supercharts
Market capitalization
‪19.20 M‬EUR
‪−1.92 M‬EUR
0.00EUR
‪1.72 B‬
Beta (1Y)
−0.90

About Solvonis Therapeutics Plc


CEO
Anthony Tennyson
Headquarters
London
Founded
2017
ISIN
GB00BMD1Z199
FIGI
BBG01V8P7YJ4
Solvonis Therapeutics Plc is a holding company, which engages in the development and production of polymer. It improves existing products and processing methodologies by enhancing performance, simplifying manufacturing, reducing material consumption, widening the choice of feedstocks, and reducing costs. The company was founded by Victor Bolduev on May 18, 2017 and is headquartered in London, the United Kingdom.

Check out other big names from the same industry as J4I.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of J4I is 0.00 EUR — it hasn't changed in the past 24 hours. Watch Solvonis Therapeutics Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Solvonis Therapeutics Plc stocks are traded under the ticker J4I.
J4I stock has risen by 400.00% compared to the previous week, the month change is a 400.00% rise, over the last year Solvonis Therapeutics Plc has showed a 400.00% increase.
We've gathered analysts' opinions on Solvonis Therapeutics Plc future price: according to them, J4I price has a max estimate of 0.02 EUR and a min estimate of 0.02 EUR. Watch J4I chart and read a more detailed Solvonis Therapeutics Plc stock forecast: see what analysts think of Solvonis Therapeutics Plc and suggest that you do with its stocks.
J4I reached its all-time high on Jul 14, 2025 with the price of 0.01 EUR, and its all-time low was 0.0005 EUR and was reached on May 30, 2025. View more price dynamics on J4I chart.
See other stocks reaching their highest and lowest prices.
J4I stock is 400.00% volatile and has beta coefficient of −0.90. Track Solvonis Therapeutics Plc stock price on the chart and check out the list of the most volatile stocks — is Solvonis Therapeutics Plc there?
Today Solvonis Therapeutics Plc has the market capitalization of ‪19.50 M‬, it has decreased by −11.27% over the last week.
Yes, you can track Solvonis Therapeutics Plc financials in yearly and quarterly reports right on TradingView.
J4I net income for the last quarter is ‪−404.86 K‬ EUR, while the quarter before that showed ‪−755.42 K‬ EUR of net income which accounts for 46.41% change. Track more Solvonis Therapeutics Plc financial stats to get the full picture.
No, J4I doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, J4I shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Solvonis Therapeutics Plc stock right from TradingView charts — choose your broker and connect to your account.